SERA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
SERA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Sera Prognostics's Revenue per Share for the three months ended in Dec. 2024 was $0.00.
During the past 12 months, Sera Prognostics's average Revenue per Share Growth Rate was -80.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -12.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 25.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 6 years, the highest 3-Year average Revenue per Share Growth Rate of Sera Prognostics was 115.40% per year. The lowest was -12.60% per year. And the median was 65.10% per year.
For the Medical Devices subindustry, Sera Prognostics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, Sera Prognostics's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where Sera Prognostics's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Sera Prognostics (NAS:SERA) 3-Year Revenue Growth Rate Explanation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
Thank you for viewing the detailed overview of Sera Prognostics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Mansoor Raza Mirza | director | C/O KARYOPHARM THERAPEUTICS INC., 2 MERCER ROAD, NATICK MA 01760 |
Austin Aerts | officer: Chief Financial Officer | 2479 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Robert Gardner Harrison | officer: Chief Information Officer | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Zhenya Lindgardt | director | C/O SERA PROGNOSTICS INC, 2749 EAST PARLEYS WAY SUITE 200, SALT LAKE CITY UT 84109 |
John J. Boniface | officer: Chief Scientific Officer | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Benjamin Jackson | officer: General Counsel | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Paul Kearney | officer: Chief Data Officer | 2749 E. PARLEYS WAY, C/O SERA PROGNOSTICS, INC., SALT LAKE CITY UT 84109 |
Joshua Phillips | director | C/O SERA PROGNOSTICS, INC., 2749 EAST PARLEYS WAY, SUITE 200, SALT LAKE CITY UT 84109 |
Jane F Barlow | director | 6800 BROKEN SOUND PARKWAY NW, 3RD FLOOR, BOCA RATON FL 33487 |
Michael R Foley | officer: Chief Medical Officer | C/O SERA PROGNOSTICS INC, 2749 EAST PARLEYS WAY SUITE 200, SALT LAKE CITY UT 04109 |
Sandra Aj Lawrence | director | C/O EVERGY, INC., 1200 MAIN STREET, KANSAS CITY MO 64105 |
Douglas Fisher | officer: Chief Business Officer | 587 PATROL RD, WOODSIDE CA 94062 |
Gregory C Critchfield | director, officer: Chief Executive Officer | 320 WAKARA WAY, SALT LAKE CITY UT 84108 |
Blue Ox Healthcare Partners Sp, Llc | 10 percent owner | 135 E. 57TH STREET, 23RD FLOOR, NEW YORK NY 10022 |
Bxhcp Sp Ii, Llc | 10 percent owner | 135 E 57TH STREET, 23RD FLOOR, NEW YORK NY 10022 |
From GuruFocus
By GuruFocus News • 11-06-2024
By PRNewswire • 02-21-2025
By PRNewswire • 02-11-2025
By PRNewswire • 03-19-2025
By PRNewswire • 10-28-2024
By PRNewswire • 04-29-2024
By GuruFocus News • 03-19-2025
By PRNewswire • 01-27-2025
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.